The compound induces S-phase cell cycle arrest and subsequent apoptosis in cancer cells, with an associated downregulation of Bcl-xL and Bcl-2, and an upregulation of Bax and cytochrome C [73]. The gene discussed is BCL2; the disease is cancer.